Home
Home

M&A

Elan rejects Royalty bid as grossly undervaluing its prospects

Elan rejects Royalty bid as grossly undervaluing its prospects
Reuters

Russia blocks Abbott Laboratories - Petrovax merger

Russia blocks Abbott Laboratories - Petrovax merger
domain-b

Russia rejects Abbott Laboratories' plan to buy Petrovax

Russia rejects Abbott Laboratories' plan to buy Petrovax
Reuters

Illumina: Thermo Fisher-Life Deal Unlikely To Threaten Its Market-Leading Position

Illumina: Thermo Fisher-Life Deal Unlikely To Threaten Its Market-Leading Position
Seeking Alpha

Mexico says Nestle to sell Pfizer's Mexico baby food unit

Mexico says Nestle to sell Pfizer's Mexico baby food unit
Reuters

Royalty Pharma sweetens offer for Elan

Royalty Pharma sweetens offer for Elan
Reuters

BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce New Merger Agreement

BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce New Merger Agreement
Yahoo/BusinessWire

Firm ranks top 5 biotech deals in evolving pharma R&D landscape

Firm ranks top 5 biotech deals in evolving pharma R&D landscape
Fierce Biotech

Prolor Said to Hire Jefferies to Evaluate Alternatives

Prolor Said to Hire Jefferies to Evaluate Alternatives
Bloomberg

Merz Pharma drops out of race for Obagi Medical

Merz Pharma drops out of race for Obagi Medical
Reuters